Advanced Solid Tumors

Showing NaN - NaN of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors Trial in United States (REGN7075, cemiplimab)

Recruiting
  • Advanced Solid Tumors
  • San Francisco, California
  • +9 more
Jan 30, 2023

Advanced Solid Tumors Trial in Worldwide (AMG 650)

Active, not recruiting
  • Advanced Solid Tumors
  • AMG 650
  • Los Angeles, California
  • +21 more
Jan 26, 2023

Advanced Solid Tumors Trial in Worldwide (MK-1084, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +39 more
Jan 25, 2023

Advanced Solid Tumors Trial in Worldwide (PDR001)

Recruiting
  • Advanced Solid Tumors
  • New York, New York
  • +42 more
Jan 23, 2023

Advanced Solid Tumors Trial in Worldwide (MK-1088, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • Miami, Florida
  • +10 more
Jan 12, 2023

Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +41 more
Jan 10, 2023

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

Advanced Solid Tumors Trial in Worldwide (ASP1951, pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Tucson, Arizona
  • +31 more
Jan 10, 2023

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +68 more
Jan 10, 2023

Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Palo Alto, California
  • +15 more
Jan 6, 2023

Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)

Recruiting
  • Advanced Solid Tumors
  • Kirsten Rat Sarcoma (KRAS) pG12C Mutation
  • Tucson, Arizona
  • +83 more
Dec 28, 2022

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • Boston, Massachusetts
  • +9 more
Dec 22, 2022

Advanced Solid Tumors Trial in Worldwide (ALKS 4230, ALKS 4230 + pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • ALKS 4230 + pembrolizumab
  • Denver, Colorado
  • +30 more
Nov 23, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Advanced Solid Tumors Trial in Worldwide (INCB081776, INCMGA00012)

Recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +19 more
Nov 10, 2022

Advanced Solid Tumors Trial in United States (FF-10850 Topotecan Liposome Injection)

Recruiting
  • Advanced Solid Tumors
  • FF-10850 Topotecan Liposome Injection
  • Scottsdale, Arizona
  • +5 more
Oct 19, 2022

Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))

Active, not recruiting
  • Advanced Solid Tumors
  • DS-8201a (DP1)
  • +2 more
  • San Diego, California
  • +13 more
Oct 4, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Advanced Solid Tumors Trial in United States (GS-3583)

Active, not recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +3 more
Jul 22, 2022

Breast Cancer, Prostate Cancer, Advanced Solid Tumors Trial in Middletown, Harrison, New York (AZD5363, Enzalutamide,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Middletown, New Jersey
  • +2 more
Jul 5, 2022

Advanced Solid Tumors Trial in Worldwide (ASP8374, Pembrolizumab)

Completed
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +53 more
May 18, 2022

Advanced Solid Tumors Trial in Worldwide (MSC2490484A (M3814), Fractionated RT, Cisplatin)

Completed
  • Advanced Solid Tumors
  • MSC2490484A (M3814)
  • +2 more
  • Fresno, California
  • +25 more
Apr 6, 2022

Advanced Solid Tumors, Sarcoma Trial in United States (TP-1287)

Recruiting
  • Advanced Solid Tumors
  • Sarcoma
  • Los Angeles, California
  • +9 more
Apr 4, 2022

Cancer, Advanced Solid Tumors Trial in United States (BBI608, BBI503)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Chicago, Illinois
  • +10 more
Apr 4, 2022

Advanced Solid Tumors Trial in United Kingdom, United States (MEDI5395, Durvalumab)

Active, not recruiting
  • Advanced Solid Tumors
  • MEDI5395
  • Durvalumab
  • Phoenix, Arizona
  • +9 more
Mar 22, 2022